The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Martin Wabitsch MD, PhD is Professor of Pediatrics at the University of Ulm, Germany and is the Head of the Division of Pediatric Endocrinology and Diabetes at the Department of Pediatrics and Adolescents Medicine in Ulm’s University Hospital. His clinical research focus comprises the physiology of body weight regulation in children, genetic obesity and leptin deficiency in human. His experimental research focus is the biology of the human adipocyte.
Dr. Wabitsch has had his clinical and experimental training at the Universities in Berlin (Free University), Ulm, Baltimore (Johns Hopkins) and Nice (Sophia Antipolis). Within an ESPE research fellowship he performed studies on the growth hormone receptor at the Hagedorn Research Institute. At present he is a member of the ESPE Science Committee.